Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Operating Expenses (2022 - 2025)

Historic Operating Expenses for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to $78.4 million.

  • Praxis Precision Medicines' Operating Expenses rose 3714.23% to $78.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $300.6 million, marking a year-over-year increase of 8148.35%. This contributed to the annual value of $208.7 million for FY2024, which is 6202.3% up from last year.
  • Latest data reveals that Praxis Precision Medicines reported Operating Expenses of $78.4 million as of Q3 2025, which was up 3714.23% from $76.1 million recorded in Q2 2025.
  • Over the past 5 years, Praxis Precision Medicines' Operating Expenses peaked at $78.4 million during Q3 2025, and registered a low of $26.0 million during Q3 2023.
  • Its 4-year average for Operating Expenses is $52.1 million, with a median of $44.3 million in 2022.
  • Per our database at Business Quant, Praxis Precision Medicines' Operating Expenses crashed by 4368.26% in 2023 and then surged by 15217.68% in 2024.
  • Praxis Precision Medicines' Operating Expenses (Quarter) stood at $41.5 million in 2022, then plummeted by 31.68% to $28.3 million in 2023, then soared by 152.18% to $71.4 million in 2024, then increased by 9.72% to $78.4 million in 2025.
  • Its Operating Expenses was $78.4 million in Q3 2025, compared to $76.1 million in Q2 2025 and $74.7 million in Q1 2025.